Neuroimmune perturbations and vascular inflammation observed in people with COVID-19
may warrant investigation of immune-modulating interventions to ameliorate neurological …

Objective Reports of neurological involvement during Severe Acute Respiratory Syndrome
Coronavirus-2 (SARS-CoV-2) infection course are increasingly described. The aim of this …

With the progression of investigations on the pathogenesis of severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), neurological complications have emerged as a …

Since the initial reports of coronavirus disease 2019 (COVID-19) in China in late 2019,
infections from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have …

COVID-19 is a severe respiratory disease caused by the newly identified human coronavirus
(HCoV) Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). The virus was …

The recent outbreak of SARS-CoV-2 infections that causes coronavirus-induced disease of
2019 (COVID-19) is the defining and unprecedented global health crisis of our time in both …

Although some neurologic complications should be treated with standard practices, further
investigations are still needed to determine the optimal treatment of COVID-related …

The novel coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), which is believed to have emerged from an animal …

Importance Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in
December 2019, causing human coronavirus disease 2019 (COVID-19), which has now …

2185 person in 2019. The WHO has called it a global public health emergency (WHO).
Activation of NF-B in SARS-CoV-2 infection may be linked to immune cell pathogenicity …